Global Contraceptives Sales Market Report 2023

Publisher Name :
Date: 04-Jan-2023
No. of pages: 141
Inquire Before Buying

The global Contraceptives market is segmented by company, region (country), type and end user. Players, stakeholders, and other participants in the global Contraceptives market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and end user for the period 2018-2029.

Segment by Type

- Pills

- Injectable

- Condoms

- Vaginal Rings

- IUDs

- Subdermal Implants

- Others

Segment by End User

- 15-24 years

- 25-34 years

- 35-44 years

- Above 44 years

By Region

- United States

- Europe

- China

- Japan

- Southeast Asia

- India

- Other Regions

By Company

- Bayer AG

- Pfizer, Inc

- Teva Pharmaceutical Industries Ltd

- Merck & Co., Inc

- Actavis, Inc.

- Johnson & Johnson

- Gedeon Richter

- Novo Nordisk A/S

- ZiZhu

- Baijingyu

- Huazhong

- Sine

- Reckitt

- AbbVie

- Church & Dwight

- The Cooper Companies

- TherapeuticsMD

- Afaxys

- Mithra Pharmaceuticals

Global Contraceptives Sales Market Report 2023

Table of Contents
1 Contraceptives Market Overview
1.1 Contraceptives Product Scope
1.2 Contraceptives Segment by Type
1.2.1 Global Contraceptives Sales by Type (2018 & 2022 & 2029)
1.2.2 Pills
1.2.3 Injectable
1.2.4 Condoms
1.2.5 Vaginal Rings
1.2.6 IUDs
1.2.7 Subdermal Implants
1.2.8 Others
1.3 Contraceptives Segment by End User
1.3.1 Global Contraceptives Sales Comparison by End User (2018 & 2022 & 2029)
1.3.2 15-24 years
1.3.3 25-34 years
1.3.4 35-44 years
1.3.5 Above 44 years
1.4 Contraceptives Market Estimates and Forecasts (2018-2029)
1.4.1 Global Contraceptives Market Size in Value Growth Rate (2018-2029)
1.4.2 Global Contraceptives Market Size in Volume Growth Rate (2018-2029)
1.4.3 Global Contraceptives Price Trends (2018-2029)
2 Contraceptives Estimates and Forecasts by Region
2.1 Global Contraceptives Market Size by Region: 2018 VS 2022 VS 2029
2.2 Global Contraceptives Retrospective Market Scenario by Region (2018-2023)
2.2.1 Global Contraceptives Sales Market Share by Region (2018-2023)
2.2.2 Global Contraceptives Revenue Market Share by Region (2018-2023)
2.3 Global Contraceptives Market Estimates and Forecasts by Region (2024-2029)
2.3.1 Global Contraceptives Sales Estimates and Forecasts by Region (2024-2029)
2.3.2 Global Contraceptives Revenue Forecast by Region (2024-2029)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Contraceptives Estimates and Projections (2018-2029)
2.4.2 Europe Contraceptives Estimates and Projections (2018-2029)
2.4.3 China Contraceptives Estimates and Projections (2018-2029)
2.4.4 Japan Contraceptives Estimates and Projections (2018-2029)
2.4.5 Southeast Asia Contraceptives Estimates and Projections (2018-2029)
2.4.6 India Contraceptives Estimates and Projections (2018-2029)
3 Global Contraceptives Competition Landscape by Players
3.1 Global Top Contraceptives Players by Sales (2018-2023)
3.2 Global Top Contraceptives Players by Revenue (2018-2023)
3.3 Global Contraceptives Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Contraceptives as of 2022)
3.4 Global Contraceptives Average Price by Company (2018-2023)
3.5 Manufacturers Contraceptives Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Contraceptives Market Size by Type
4.1 Global Contraceptives Historic Market Review by Type (2018-2023)
4.1.1 Global Contraceptives Sales by Type (2018-2023)
4.1.2 Global Contraceptives Revenue by Type (2018-2023)
4.1.3 Global Contraceptives Price by Type (2018-2023)
4.2 Global Contraceptives Market Estimates and Forecasts by Type (2024-2029)
4.2.1 Global Contraceptives Sales Forecast by Type (2024-2029)
4.2.2 Global Contraceptives Revenue Forecast by Type (2024-2029)
4.2.3 Global Contraceptives Price Forecast by Type (2024-2029)
5 Global Contraceptives Market Size by End User
5.1 Global Contraceptives Historic Market Review by End User (2018-2023)
5.1.1 Global Contraceptives Sales by End User (2018-2023)
5.1.2 Global Contraceptives Revenue by End User (2018-2023)
5.1.3 Global Contraceptives Price by End User (2018-2023)
5.2 Global Contraceptives Market Estimates and Forecasts by End User (2024-2029)
5.2.1 Global Contraceptives Sales Forecast by End User (2024-2029)
5.2.2 Global Contraceptives Revenue Forecast by End User (2024-2029)
5.2.3 Global Contraceptives Price Forecast by End User (2024-2029)
6 United States Contraceptives Market Facts & Figures
6.1 United States Contraceptives Sales by Company
6.1.1 United States Contraceptives Sales by Company (2018-2023)
6.1.2 United States Contraceptives Revenue by Company (2018-2023)
6.2 United States Contraceptives Sales Breakdown by Type
6.2.1 United States Contraceptives Sales Breakdown by Type (2018-2023)
6.2.2 United States Contraceptives Sales Breakdown by Type (2024-2029)
6.3 United States Contraceptives Sales Breakdown by End User
6.3.1 United States Contraceptives Sales Breakdown by End User (2018-2023)
6.3.2 United States Contraceptives Sales Breakdown by End User (2024-2029)
7 Europe Contraceptives Market Facts & Figures
7.1 Europe Contraceptives Sales by Company
7.1.1 Europe Contraceptives Sales by Company (2018-2023)
7.1.2 Europe Contraceptives Revenue by Company (2018-2023)
7.2 Europe Contraceptives Sales Breakdown by Type
7.2.1 Europe Contraceptives Sales Breakdown by Type (2018-2023)
7.2.2 Europe Contraceptives Sales Breakdown by Type (2024-2029)
7.3 Europe Contraceptives Sales Breakdown by End User
7.3.1 Europe Contraceptives Sales Breakdown by End User (2018-2023)
7.3.2 Europe Contraceptives Sales Breakdown by End User (2024-2029)
8 China Contraceptives Market Facts & Figures
8.1 China Contraceptives Sales by Company
8.1.1 China Contraceptives Sales by Company (2018-2023)
8.1.2 China Contraceptives Revenue by Company (2018-2023)
8.2 China Contraceptives Sales Breakdown by Type
8.2.1 China Contraceptives Sales Breakdown by Type (2018-2023)
8.2.2 China Contraceptives Sales Breakdown by Type (2024-2029)
8.3 China Contraceptives Sales Breakdown by End User
8.3.1 China Contraceptives Sales Breakdown by End User (2018-2023)
8.3.2 China Contraceptives Sales Breakdown by End User (2024-2029)
9 Japan Contraceptives Market Facts & Figures
9.1 Japan Contraceptives Sales by Company
9.1.1 Japan Contraceptives Sales by Company (2018-2023)
9.1.2 Japan Contraceptives Revenue by Company (2018-2023)
9.2 Japan Contraceptives Sales Breakdown by Type
9.2.1 Japan Contraceptives Sales Breakdown by Type (2018-2023)
9.2.2 Japan Contraceptives Sales Breakdown by Type (2024-2029)
9.3 Japan Contraceptives Sales Breakdown by End User
9.3.1 Japan Contraceptives Sales Breakdown by End User (2018-2023)
9.3.2 Japan Contraceptives Sales Breakdown by End User (2024-2029)
10 Southeast Asia Contraceptives Market Facts & Figures
10.1 Southeast Asia Contraceptives Sales by Company
10.1.1 Southeast Asia Contraceptives Sales by Company (2018-2023)
10.1.2 Southeast Asia Contraceptives Revenue by Company (2018-2023)
10.2 Southeast Asia Contraceptives Sales Breakdown by Type
10.2.1 Southeast Asia Contraceptives Sales Breakdown by Type (2018-2023)
10.2.2 Southeast Asia Contraceptives Sales Breakdown by Type (2024-2029)
10.3 Southeast Asia Contraceptives Sales Breakdown by End User
10.3.1 Southeast Asia Contraceptives Sales Breakdown by End User (2018-2023)
10.3.2 Southeast Asia Contraceptives Sales Breakdown by End User (2024-2029)
11 India Contraceptives Market Facts & Figures
11.1 India Contraceptives Sales by Company
11.1.1 India Contraceptives Sales by Company (2018-2023)
11.1.2 India Contraceptives Revenue by Company (2018-2023)
11.2 India Contraceptives Sales Breakdown by Type
11.2.1 India Contraceptives Sales Breakdown by Type (2018-2023)
11.2.2 India Contraceptives Sales Breakdown by Type (2024-2029)
11.3 India Contraceptives Sales Breakdown by End User
11.3.1 India Contraceptives Sales Breakdown by End User (2018-2023)
11.3.2 India Contraceptives Sales Breakdown by End User (2024-2029)
12 Company Profiles and Key Figures in Contraceptives Business
12.1 Bayer AG
12.1.1 Bayer AG Corporation Information
12.1.2 Bayer AG Business Overview
12.1.3 Bayer AG Contraceptives Sales, Revenue and Gross Margin (2018-2023)
12.1.4 Bayer AG Contraceptives Products Offered
12.1.5 Bayer AG Recent Development
12.2 Pfizer, Inc
12.2.1 Pfizer, Inc Corporation Information
12.2.2 Pfizer, Inc Business Overview
12.2.3 Pfizer, Inc Contraceptives Sales, Revenue and Gross Margin (2018-2023)
12.2.4 Pfizer, Inc Contraceptives Products Offered
12.2.5 Pfizer, Inc Recent Development
12.3 Teva Pharmaceutical Industries Ltd
12.3.1 Teva Pharmaceutical Industries Ltd Corporation Information
12.3.2 Teva Pharmaceutical Industries Ltd Business Overview
12.3.3 Teva Pharmaceutical Industries Ltd Contraceptives Sales, Revenue and Gross Margin (2018-2023)
12.3.4 Teva Pharmaceutical Industries Ltd Contraceptives Products Offered
12.3.5 Teva Pharmaceutical Industries Ltd Recent Development
12.4 Merck & Co., Inc
12.4.1 Merck & Co., Inc Corporation Information
12.4.2 Merck & Co., Inc Business Overview
12.4.3 Merck & Co., Inc Contraceptives Sales, Revenue and Gross Margin (2018-2023)
12.4.4 Merck & Co., Inc Contraceptives Products Offered
12.4.5 Merck & Co., Inc Recent Development
12.5 Actavis, Inc.
12.5.1 Actavis, Inc. Corporation Information
12.5.2 Actavis, Inc. Business Overview
12.5.3 Actavis, Inc. Contraceptives Sales, Revenue and Gross Margin (2018-2023)
12.5.4 Actavis, Inc. Contraceptives Products Offered
12.5.5 Actavis, Inc. Recent Development
12.6 Johnson & Johnson
12.6.1 Johnson & Johnson Corporation Information
12.6.2 Johnson & Johnson Business Overview
12.6.3 Johnson & Johnson Contraceptives Sales, Revenue and Gross Margin (2018-2023)
12.6.4 Johnson & Johnson Contraceptives Products Offered
12.6.5 Johnson & Johnson Recent Development
12.7 Gedeon Richter
12.7.1 Gedeon Richter Corporation Information
12.7.2 Gedeon Richter Business Overview
12.7.3 Gedeon Richter Contraceptives Sales, Revenue and Gross Margin (2018-2023)
12.7.4 Gedeon Richter Contraceptives Products Offered
12.7.5 Gedeon Richter Recent Development
12.8 Novo Nordisk A/S
12.8.1 Novo Nordisk A/S Corporation Information
12.8.2 Novo Nordisk A/S Business Overview
12.8.3 Novo Nordisk A/S Contraceptives Sales, Revenue and Gross Margin (2018-2023)
12.8.4 Novo Nordisk A/S Contraceptives Products Offered
12.8.5 Novo Nordisk A/S Recent Development
12.9 ZiZhu
12.9.1 ZiZhu Corporation Information
12.9.2 ZiZhu Business Overview
12.9.3 ZiZhu Contraceptives Sales, Revenue and Gross Margin (2018-2023)
12.9.4 ZiZhu Contraceptives Products Offered
12.9.5 ZiZhu Recent Development
12.10 Baijingyu
12.10.1 Baijingyu Corporation Information
12.10.2 Baijingyu Business Overview
12.10.3 Baijingyu Contraceptives Sales, Revenue and Gross Margin (2018-2023)
12.10.4 Baijingyu Contraceptives Products Offered
12.10.5 Baijingyu Recent Development
12.11 Huazhong
12.11.1 Huazhong Corporation Information
12.11.2 Huazhong Business Overview
12.11.3 Huazhong Contraceptives Sales, Revenue and Gross Margin (2018-2023)
12.11.4 Huazhong Contraceptives Products Offered
12.11.5 Huazhong Recent Development
12.12 Sine
12.12.1 Sine Corporation Information
12.12.2 Sine Business Overview
12.12.3 Sine Contraceptives Sales, Revenue and Gross Margin (2018-2023)
12.12.4 Sine Contraceptives Products Offered
12.12.5 Sine Recent Development
12.13 Reckitt
12.13.1 Reckitt Corporation Information
12.13.2 Reckitt Business Overview
12.13.3 Reckitt Contraceptives Sales, Revenue and Gross Margin (2018-2023)
12.13.4 Reckitt Contraceptives Products Offered
12.13.5 Reckitt Recent Development
12.14 AbbVie
12.14.1 AbbVie Corporation Information
12.14.2 AbbVie Business Overview
12.14.3 AbbVie Contraceptives Sales, Revenue and Gross Margin (2018-2023)
12.14.4 AbbVie Contraceptives Products Offered
12.14.5 AbbVie Recent Development
12.15 Church & Dwight
12.15.1 Church & Dwight Corporation Information
12.15.2 Church & Dwight Business Overview
12.15.3 Church & Dwight Contraceptives Sales, Revenue and Gross Margin (2018-2023)
12.15.4 Church & Dwight Contraceptives Products Offered
12.15.5 Church & Dwight Recent Development
12.16 The Cooper Companies
12.16.1 The Cooper Companies Corporation Information
12.16.2 The Cooper Companies Business Overview
12.16.3 The Cooper Companies Contraceptives Sales, Revenue and Gross Margin (2018-2023)
12.16.4 The Cooper Companies Contraceptives Products Offered
12.16.5 The Cooper Companies Recent Development
12.17 TherapeuticsMD
12.17.1 TherapeuticsMD Corporation Information
12.17.2 TherapeuticsMD Business Overview
12.17.3 TherapeuticsMD Contraceptives Sales, Revenue and Gross Margin (2018-2023)
12.17.4 TherapeuticsMD Contraceptives Products Offered
12.17.5 TherapeuticsMD Recent Development
12.18 Afaxys
12.18.1 Afaxys Corporation Information
12.18.2 Afaxys Business Overview
12.18.3 Afaxys Contraceptives Sales, Revenue and Gross Margin (2018-2023)
12.18.4 Afaxys Contraceptives Products Offered
12.18.5 Afaxys Recent Development
12.19 Mithra Pharmaceuticals
12.19.1 Mithra Pharmaceuticals Corporation Information
12.19.2 Mithra Pharmaceuticals Business Overview
12.19.3 Mithra Pharmaceuticals Contraceptives Sales, Revenue and Gross Margin (2018-2023)
12.19.4 Mithra Pharmaceuticals Contraceptives Products Offered
12.19.5 Mithra Pharmaceuticals Recent Development
13 Contraceptives Manufacturing Cost Analysis
13.1 Contraceptives Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Contraceptives
13.4 Contraceptives Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Contraceptives Distributors List
14.3 Contraceptives Customers
15 Market Dynamics
15.1 Contraceptives Industry Trends
15.2 Contraceptives Market Drivers
15.3 Contraceptives Market Challenges
15.4 Contraceptives Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Contraceptives Sales (US$ Million) Growth Rate by Type (2018 & 2022 & 2029)
Table 2. Global Contraceptives Sales ((US$ Million)) Comparison by End User (2018 & 2022 & 2029)
Table 3. Global Contraceptives Market Size (US$ Million) by Region: 2018 VS 2022 VS 2029
Table 4. Global Contraceptives Sales (M Units) by Region (2018-2023)
Table 5. Global Contraceptives Sales Market Share by Region (2018-2023)
Table 6. Global Contraceptives Revenue (US$ Million) Market Share by Region (2018-2023))
Table 7. Global Contraceptives Revenue Share by Region (2018-2023)
Table 8. Global Contraceptives Sales (M Units) Forecast by Region (2024-2029)
Table 9. Global Contraceptives Sales Market Share Forecast by Region (2024-2029)
Table 10. Global Contraceptives Revenue (US$ Million) Forecast by Region (2024-2029)
Table 11. Global Contraceptives Revenue Share Forecast by Region (2024-2029)
Table 12. Global Contraceptives Sales by Company (M Units) & (2018-2023)
Table 13. Global Contraceptives Sales Share by Company (2018-2023)
Table 14. Global Contraceptives Revenue by Company (US$ Million) & (2018-2023)
Table 15. Global Contraceptives Revenue Share by Company (2018-2023)
Table 16. Global Contraceptives by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Contraceptives as of 2022)
Table 17. Global Market Contraceptives Average Price by Company (USD/Unit) & (2018-2023)
Table 18. Manufacturers Contraceptives Manufacturing Sites and Area Served
Table 19. Manufacturers Contraceptives Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Contraceptives Sales by Type (2018-2023) & (M Units)
Table 22. Global Contraceptives Sales Share by Type (2018-2023)
Table 23. Global Contraceptives Revenue by Type (2018-2023) & (US$ Million)
Table 24. Global Contraceptives Price by Type (2018-2023) & (USD/Unit)
Table 25. Global Contraceptives Sales by Type (2024-2029)
Table 26. Global Contraceptives Revenue by Type (2024-2029) & (US$ Million)
Table 27. Global Contraceptives Revenue Share by Type (2024-2029)
Table 28. Global Contraceptives Price by Type (2024-2029) & (USD/Unit)
Table 29. Global Contraceptives Sales by End User (2018-2023) & (M Units)
Table 30. Global Contraceptives Sales Share by End User (2018-2023)
Table 31. Global Contraceptives Revenue by End User (2018-2023) & (US$ Million)
Table 32. Global Contraceptives Price by End User (2018-2023) & (USD/Unit)
Table 33. Global Contraceptives Sales by End User (2024-2029) & (M Units)
Table 34. Global Contraceptives Sales Share by End User (2024-2029)
Table 35. Global Contraceptives Revenue by End User (2024-2029) & (US$ Million)
Table 36. Global Contraceptives Revenue Share by End User (2024-2029)
Table 37. Global Contraceptives Price by End User (2024-2029) & (USD/Unit)
Table 38. United States Contraceptives Sales by Company (2018-2023) & (M Units)
Table 39. United States Contraceptives Sales Market Share by Company (2018-2023)
Table 40. United States Contraceptives Revenue by Company (2018-2023) & (US$ Million)
Table 41. United States Contraceptives Revenue Market Share by Company (2018-2023)
Table 42. United States Contraceptives Sales by Type (2018-2023) & (M Units)
Table 43. United States Contraceptives Sales Market Share by Type (2018-2023)
Table 44. United States Contraceptives Sales by Type (2024-2029) & (M Units)
Table 45. United States Contraceptives Sales Market Share by Type (2024-2029)
Table 46. United States Contraceptives Sales by End User (2018-2023) & (M Units)
Table 47. United States Contraceptives Sales Market Share by End User (2018-2023)
Table 48. United States Contraceptives Sales by End User (2024-2029) & (M Units)
Table 49. United States Contraceptives Sales Market Share by End User (2024-2029)
Table 50. Europe Contraceptives Sales by Company (2018-2023) & (M Units)
Table 51. Europe Contraceptives Sales Market Share by Company (2018-2023)
Table 52. Europe Contraceptives Revenue by Company (2018-2023) & (US$ Million)
Table 53. Europe Contraceptives Revenue Market Share by Company (2018-2023)
Table 54. Europe Contraceptives Sales by Type (2018-2023) & (M Units)
Table 55. Europe Contraceptives Sales Market Share by Type (2018-2023)
Table 56. Europe Contraceptives Sales by Type (2024-2029) & (M Units)
Table 57. Europe Contraceptives Sales Market Share by Type (2024-2029)
Table 58. Europe Contraceptives Sales by End User (2018-2023) & (M Units)
Table 59. Europe Contraceptives Sales Market Share by End User (2018-2023)
Table 60. Europe Contraceptives Sales by End User (2024-2029) & (M Units)
Table 61. Europe Contraceptives Sales Market Share by End User (2024-2029)
Table 62. China Contraceptives Sales by Company (2018-2023) & (M Units)
Table 63. China Contraceptives Sales Market Share by Company (2018-2023)
Table 64. China Contraceptives Revenue by Company (2018-2023) & (US$ Million)
Table 65. China Contraceptives Revenue Market Share by Company (2018-2023)
Table 66. China Contraceptives Sales by Type (2018-2023) & (M Units)
Table 67. China Contraceptives Sales Market Share by Type (2018-2023)
Table 68. China Contraceptives Sales by Type (2024-2029) & (M Units)
Table 69. China Contraceptives Sales Market Share by Type (2024-2029)
Table 70. China Contraceptives Sales by End User (2018-2023) & (M Units)
Table 71. China Contraceptives Sales Market Share by End User (2018-2023)
Table 72. China Contraceptives Sales by End User (2024-2029) & (M Units)
Table 73. China Contraceptives Sales Market Share by End User (2024-2029)
Table 74. Japan Contraceptives Sales by Company (2018-2023) & (M Units)
Table 75. Japan Contraceptives Sales Market Share by Company (2018-2023)
Table 76. Japan Contraceptives Revenue by Company (2018-2023) & (US$ Million)
Table 77. Japan Contraceptives Revenue Market Share by Company (2018-2023)
Table 78. Japan Contraceptives Sales by Type (2018-2023) & (M Units)
Table 79. Japan Contraceptives Sales Market Share by Type (2018-2023)
Table 80. Japan Contraceptives Sales by Type (2024-2029) & (M Units)
Table 81. Japan Contraceptives Sales Market Share by Type (2024-2029)
Table 82. Japan Contraceptives Sales by End User (2018-2023) & (M Units)
Table 83. Japan Contraceptives Sales Market Share by End User (2018-2023)
Table 84. Japan Contraceptives Sales by End User (2024-2029) & (M Units)
Table 85. Japan Contraceptives Sales Market Share by End User (2024-2029)
Table 86. Southeast Asia Contraceptives Sales by Company (2018-2023) & (M Units)
Table 87. Southeast Asia Contraceptives Sales Market Share by Company (2018-2023)
Table 88. Southeast Asia Contraceptives Revenue by Company (2018-2023) & (US$ Million)
Table 89. Southeast Asia Contraceptives Revenue Market Share by Company (2018-2023)
Table 90. Southeast Asia Contraceptives Sales by Type (2018-2023) & (M Units)
Table 91. Southeast Asia Contraceptives Sales Market Share by Type (2018-2023)
Table 92. Southeast Asia Contraceptives Sales by Type (2024-2029) & (M Units)
Table 93. Southeast Asia Contraceptives Sales Market Share by Type (2024-2029)
Table 94. Southeast Asia Contraceptives Sales by End User (2018-2023) & (M Units)
Table 95. Southeast Asia Contraceptives Sales Market Share by End User (2018-2023)
Table 96. Southeast Asia Contraceptives Sales by End User (2024-2029) & (M Units)
Table 97. Southeast Asia Contraceptives Sales Market Share by End User (2024-2029)
Table 98. India Contraceptives Sales by Company (2018-2023) & (M Units)
Table 99. India Contraceptives Sales Market Share by Company (2018-2023)
Table 100. India Contraceptives Revenue by Company (2018-2023) & (US$ Million)
Table 101. India Contraceptives Revenue Market Share by Company (2018-2023)
Table 102. India Contraceptives Sales by Type (2018-2023) & (M Units)
Table 103. India Contraceptives Sales Market Share by Type (2018-2023)
Table 104. India Contraceptives Sales by Type (2024-2029) & (M Units)
Table 105. India Contraceptives Sales Market Share by Type (2024-2029)
Table 106. India Contraceptives Sales by End User (2018-2023) & (M Units)
Table 107. India Contraceptives Sales Market Share by End User (2018-2023)
Table 108. India Contraceptives Sales by End User (2024-2029) & (M Units)
Table 109. India Contraceptives Sales Market Share by End User (2024-2029)
Table 110. Bayer AG Corporation Information
Table 111. Bayer AG Description and Business Overview
Table 112. Bayer AG Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Bayer AG Contraceptives Product
Table 114. Bayer AG Recent Development
Table 115. Pfizer, Inc Corporation Information
Table 116. Pfizer, Inc Description and Business Overview
Table 117. Pfizer, Inc Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. Pfizer, Inc Contraceptives Product
Table 119. Pfizer, Inc Recent Development
Table 120. Teva Pharmaceutical Industries Ltd Corporation Information
Table 121. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 122. Teva Pharmaceutical Industries Ltd Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 123. Teva Pharmaceutical Industries Ltd Contraceptives Product
Table 124. Teva Pharmaceutical Industries Ltd Recent Development
Table 125. Merck & Co., Inc Corporation Information
Table 126. Merck & Co., Inc Description and Business Overview
Table 127. Merck & Co., Inc Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 128. Merck & Co., Inc Contraceptives Product
Table 129. Merck & Co., Inc Recent Development
Table 130. Actavis, Inc. Corporation Information
Table 131. Actavis, Inc. Description and Business Overview
Table 132. Actavis, Inc. Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 133. Actavis, Inc. Contraceptives Product
Table 134. Actavis, Inc. Recent Development
Table 135. Johnson & Johnson Corporation Information
Table 136. Johnson & Johnson Description and Business Overview
Table 137. Johnson & Johnson Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 138. Johnson & Johnson Contraceptives Product
Table 139. Johnson & Johnson Recent Development
Table 140. Gedeon Richter Corporation Information
Table 141. Gedeon Richter Description and Business Overview
Table 142. Gedeon Richter Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 143. Gedeon Richter Contraceptives Product
Table 144. Gedeon Richter Recent Development
Table 145. Novo Nordisk A/S Corporation Information
Table 146. Novo Nordisk A/S Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 147. Novo Nordisk A/S Description and Business Overview
Table 148. Novo Nordisk A/S Contraceptives Product
Table 149. Novo Nordisk A/S Recent Development
Table 150. ZiZhu Corporation Information
Table 151. ZiZhu Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 152. ZiZhu Description and Business Overview
Table 153. ZiZhu Contraceptives Product
Table 154. ZiZhu Recent Development
Table 155. Baijingyu Corporation Information
Table 156. Baijingyu Description and Business Overview
Table 157. Baijingyu Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 158. Baijingyu Contraceptives Product
Table 159. Baijingyu Recent Development
Table 160. Huazhong Corporation Information
Table 161. Huazhong Description and Business Overview
Table 162. Huazhong Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 163. Huazhong Contraceptives Product
Table 164. Huazhong Recent Development
Table 165. Sine Corporation Information
Table 166. Sine Description and Business Overview
Table 167. Sine Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 168. Sine Contraceptives Product
Table 169. Sine Recent Development
Table 170. Reckitt Corporation Information
Table 171. Reckitt Description and Business Overview
Table 172. Reckitt Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 173. Reckitt Contraceptives Product
Table 174. Reckitt Recent Development
Table 175. AbbVie Corporation Information
Table 176. AbbVie Description and Business Overview
Table 177. AbbVie Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 178. AbbVie Contraceptives Product
Table 179. AbbVie Recent Development
Table 180. Church & Dwight Corporation Information
Table 181. Church & Dwight Description and Business Overview
Table 182. Church & Dwight Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 183. Church & Dwight Contraceptives Product
Table 184. Church & Dwight Recent Development
Table 185. The Cooper Companies Corporation Information
Table 186. The Cooper Companies Description and Business Overview
Table 187. The Cooper Companies Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 188. The Cooper Companies Contraceptives Product
Table 189. The Cooper Companies Recent Development
Table 190. TherapeuticsMD Corporation Information
Table 191. TherapeuticsMD Description and Business Overview
Table 192. TherapeuticsMD Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 193. TherapeuticsMD Contraceptives Product
Table 194. TherapeuticsMD Recent Development
Table 195. Afaxys Corporation Information
Table 196. Afaxys Description and Business Overview
Table 197. Afaxys Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 198. Afaxys Contraceptives Product
Table 199. Afaxys Recent Development
Table 200. Mithra Pharmaceuticals Corporation Information
Table 201. Mithra Pharmaceuticals Description and Business Overview
Table 202. Mithra Pharmaceuticals Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 203. Mithra Pharmaceuticals Contraceptives Product
Table 204. Mithra Pharmaceuticals Recent Development
Table 205. Production Base and Market Concentration Rate of Raw Material
Table 206. Key Suppliers of Raw Materials
Table 207. Contraceptives Distributors List
Table 208. Contraceptives Customers List
Table 209. Contraceptives Market Trends
Table 210. Contraceptives Market Drivers
Table 211. Contraceptives Market Challenges
Table 212. Contraceptives Market Restraints
Table 213. Research Programs/Design for This Report
Table 214. Key Data Information from Secondary Sources
Table 215. Key Data Information from Primary Sources
List of Figures
Figure 1. Contraceptives Product Picture
Figure 2. Global Contraceptives Sales (US$ Million) by Type (2018 & 2022 & 2029)
Figure 3. Global Contraceptives Sales Market Share by Type in 2022 & 2029
Figure 4. Pills Product Picture
Figure 5. Injectable Product Picture
Figure 6. Condoms Product Picture
Figure 7. Vaginal Rings Product Picture
Figure 8. IUDs Product Picture
Figure 9. Subdermal Implants Product Picture
Figure 10. Others Product Picture
Figure 11. Global Contraceptives Sales (US$ Million) by End User (2018 & 2022 & 2029)
Figure 12. Global Contraceptives Sales Market Share by End User in 2022 & 2029
Figure 13. 15-24 years Examples
Figure 14. 25-34 years Examples
Figure 15. 35-44 years Examples
Figure 16. Above 44 years Examples
Figure 17. Global Contraceptives Sales, (US$ Million), 2018 VS 2022 VS 2029
Figure 18. Global Contraceptives Sales Growth Rate (2018-2029) & (US$ Million)
Figure 19. Global Contraceptives Sales (M Units) Growth Rate (2018-2029)
Figure 20. Global Contraceptives Price Trends Growth Rate (2018-2029) & (USD/Unit)
Figure 21. Global Market Contraceptives Market Size (US$ Million) by Region:2018 VS 2022 VS 2029
Figure 22. Global Contraceptives Revenue Market Share by Region: 2018 VS 2022
Figure 23. United States Contraceptives Revenue (US$ Million) Growth Rate (2018-2029)
Figure 24. United States Contraceptives Sales (M Units) Growth Rate (2018-2029)
Figure 25. Europe Contraceptives Revenue (US$ Million) Growth Rate (2018-
  • Global Drugs for Vulvovaginal Candidiasis Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 119
    According to our LPI (LP Information) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at US$ 798.8 million in 2023. With growing demand in downstream market, the Drugs for Vulvovaginal Candidiasis is forecast to a readjusted size of US$ 890 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Drugs for Vulvovaginal Candidiasis market. Drugs for Vulvovaginal Candidiasis are expected t......
  • Global Bacterial Vaginosis Drug Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132
    According to our LPI (LP Information) latest study, the global Bacterial Vaginosis Drug market size was valued at US$ 896.6 million in 2023. With growing demand in downstream market, the Bacterial Vaginosis Drug is forecast to a readjusted size of US$ 1111.1 million by 2030 with a CAGR of 3.1% during review period. The research report highlights the growth potential of the global Bacterial Vaginosis Drug market. Bacterial Vaginosis Drug are expected to show stable growth in the future ma......
  • Global Contraceptives Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 141
    According to our LPI (LP Information) latest study, the global Contraceptives market size was valued at US$ 1870.3 million in 2023. With growing demand in downstream market, the Contraceptives is forecast to a readjusted size of US$ 2237.4 million by 2030 with a CAGR of 2.6% during review period. The research report highlights the growth potential of the global Contraceptives market. Contraceptives are expected to show stable growth in the future market. However, product differentiation,......
  • Global Drugs for Vulvovaginal Candidiasis Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 108
    According to our (Global Info Research) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at USD 840.2 million in 2023 and is forecast to a readjusted size of USD 928.4 million by 2030 with a CAGR of 1.4% during review period. The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cu......
  • Global Menopausal Hot Flashes Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 99
    Market Overview of Global Menopausal Hot Flashes market: According to our latest research, the global Menopausal Hot Flashes market looks promising in the next 5 years. As of 2022, the global Menopausal Hot Flashes market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Hot flashes during menopause are symptoms of menopause. They refer to the warmth that occurs during the transition period of ......
  • Global Bacterial Vaginosis Drug Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 139
    Report Overview: This report studies the Bacterial Vaginosis Drug market, Bacterial Vaginosis Drug is used for the treatment of Bacterial Vaginosis (BV), which also known as vaginal bacteriosis or Gardnerella vaginitis, a disease of the vagina caused by excessive bacteria. This report includes metronidazole, clindamycin drug and other drugs. The Global Bacterial Vaginosis Drug Market Size was estimated at USD 916.50 million in 2022 and is projected to reach USD 1127.18 million by 202......
  • Global Drugs for Vulvovaginal Candidiasis Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 122
    Report Overview: The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cure rates in excess of 80%. The only oral azole agent approved for this indication by the US Food and Drug Administration (FDA) is fluconazole, which also achieves a high cure rate. Therapeutic concentrations are found in vaginal secretions for a......
  • Global Bacterial Vaginosis Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 108
    Market Overview of Global Bacterial Vaginosis Drug market: According to our latest research, the global Bacterial Vaginosis Drug market looks promising in the next 5 years. As of 2022, the global Bacterial Vaginosis Drug market was estimated at USD 972.77 million, and it's anticipated to reach USD 1215.68 million in 2028, with a CAGR of 3.79% during the forecast years. Bacterial vaginosis (BV), also known as bacterial vaginosis, non-specific vaginitis is a disease that occurs......
  • Global Tocolysis Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 30-Nov-2023        Price: US 3380 Onwards        Pages: 123
    Market Overview of Global Tocolysis Drugs market: According to our latest research, the global Tocolysis Drugs market looks promising in the next 5 years. As of 2022, the global Tocolysis Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Tocolytics are medications used to suppress premature labor. Tocolytic therapy is provided when delivery would result in premature birth, postponi......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs